Picture of Maat Pharma SA logo

MAAT — Maat Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Maat Pharma Q1 Revenue At 300,000 Euros

May 5 (Reuters) - Maat Pharma SA  MAAT.PA :
    * Q1 REVENUE 300,000 EUR
    * REVENUES OF EUR 0.3 MILLION IN Q1 2022
    * AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS OF
POSITIONS
WERE EUR 41.1 MILLION

Source text for Eikon:  ID:nBw2XKNzga 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Maat Pharma SA

See all news